CLINICAL ROLE -
Specialty Drugs Pose Additional Challenges to Employers
Specialty drugs must have a proven therapeutic value to be covered by plan sponsors.
Treating Rare Diseases Comes With Different Set of Challenges
The high cost of treatment causes some payers to question coverage for these conditions.
Beyond the Cold Chain: The Evolution of Pharmaceutical Distribution
Meeting accreditation standards in the temperature-sensitive distribution process requires careful monitoring.
Asembia 2017: A Look Back and a Peek Ahead
Value-based care and direct and indirect remuneration fees among the hottest topics at annual summit.
Time is Bone: Unchecked Rheumatoid Arthritis Affects More Than Joints
Rheumatoid arthritis carries risks for several comorbidities that can affect organ systems, such as the heart and lungs.
Asembia Summit Illustrates Growth in Specialty Pharmacy
Summit provides comprehensive mix of content and education, including clinical, financial, supply chain, and industry trends.Â
The Growing Need for Specialty Curriculum in Pharmacy Schools
Hurdles remain in adding college coursework dedicated to specialty pharmacy.
Value-Based Contracts and Health Systems Specialty Pharmacy Integration: 2 Key Insights From Asembia 2017
The summit provides a place for specialty pharmacy stakeholders to discuss the industry.
Inaugural Patient Choice Awardsâ„¢ Winners Honored at Asembia
Collaboration between Specialty Pharmacy Times® and Zitter Health Insights honors exemplary efforts in the health care industry.
Closed-System Transfer Devices: Important Considerations for Pharmacists
Understanding that CSTDs are not a monolithic category of products is an important priority for pharmacists.Â
The Need for Standards in Specialty Pharmacy Data
Comprehensive data collection in specialty pharmacy more important than ever.
Asembia Specialty Pharmacy Summit Continues to Evolve
The Role of Specialty Pharmacy in Boosting Psoriatic Arthritis Outcomes
New biologic drugs coming to market could transform the standard of care.
How Specialty Pharmacies Can Help Prevent Vision Loss in Diabetic Macular Edema
New agents for vision conditions related to diabetes show promise, but come with challenges.
Must-See Specialty Pharmacy
The Asembia Specialty Pharmacy Summit Returns
The first of 2 showcase events in the specialty space brings thousands of stakeholders from pharmacies, manufacturers, and service providers.
Specialty Pharmacy: Where Are We Now and Where Are We Headed?
Consolidation and drug costs will play a key role in the future of specialty pharmacy.
Value-Based Agreements Present Significant Challenges to Specialty Stakeholders
Strategic, operational, and legal hurdles must be conquered before implementing this contract.
Specialty Pharmacy: The Secret Weapon for Successful Population Health Management
Clearly defining a patient population is necessary to create a singular care framework.
Challenges Remain in Eliminating HIV
A number of hurdles in HIV, including preventative efforts, still need to be addressed.
Conflicting Definition of Value for Payers, Other Stakeholders
Each specialty pharmacy stakeholder has a different definition of value.
Drug Pricing Concerns for Specialty Pharmacy
Ideal management of specialty drug costs involves an in-depth look at medical and pharmacy claims.
Adoption of Biosimilars in the United States Faces Significant Hurdles
Payers and providers may be less likely to encourage the use of biosimilars due to multiple concerns.
Health Care Reform Proves Challenging for Lawmakers
Expert panel at Asembia discusses hurdles in health care reform.
